echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nature: A magical discovery!

    Nature: A magical discovery!

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    All cancers appear after a period of clonal selection and subsequent clonal expansion.
    Although the evolutionary principles brought about by hereditary intratumoral heterogeneity are now becoming clearer, researchers are still unclear.
    A non-genetic mechanism that promotes intratumoral heterogeneity and malignant cloning
    .


    Recently, in a research report titled "Non-genetic determinants of malignant clonal fitness at single-cell resolution" published in the international journal Nature, scientists from the University of Melbourne and other institutions have successfully used a new type of cell barcode through research.


    All cancers appear after a period of clonal selection and subsequent clonal expansion.


    SPLINTR barcode library concept generation and verification
    .

    SPLINTR barcode library concept generation and verification
    .


    Image source: Fennell, KA, et al.
    Nature (2021).
    doi: 10.
    1038/s41586-021-04206-7

    Image source: Fennell, KA, et al.
    Nature (2021).
    doi: 10.
    1038/s41586-021-04206-7

     

    In this study, researchers found for the first time that cancer cells carrying the same genetic blueprint do not necessarily exhibit the same behavior, which poses a great challenge for researchers how to design targeting strategies
    .


    In the article, the researchers revealed the non-genetic changes in patients with acute myeloid leukemia .


    In this study, researchers found for the first time that cancer cells carrying the same genetic blueprint do not necessarily exhibit the same behavior, which poses a great challenge for researchers how to design targeting strategies


     

    This barcode technology called SPLINTR (Single-cell Profiling and LINeage TRacing) may help researchers identify specific genes expressed in each leukemia cell and monitor how this affects the behavior of cancer cells over time Later, the researchers observed that acute myeloid leukemia cells are most likely to form cancerous tumors
    .


    In the absence of genetic mutations, regulatory changes may be the key promoters of disease.


    This barcode technology called SPLINTR (Single-cell Profiling and LINeage TRacing) may help researchers identify specific genes expressed in each leukemia cell and monitor how this affects the behavior of cancer cells over time Later, the researchers observed that acute myeloid leukemia cells are most likely to form cancerous tumors


    The new technology developed by the researchers can help track changes in the regulatory genome of a single cancer cell over time, and they are happy to apply this computational analysis technology to this research field


    Image source: https:// source: https:// Dane Vassiliadis said that this study emphasizes the power of SPLINTR technology, which can not only help identify rare tumor subgroups, but also help find new therapeutic targets or biomarkers, and carry out certain clinical monitoring
    .


    The research work in this article also challenges the dogmatic view that precision medicine is only looking for new gene mutations; although all precision medicine research aims to treat patients based on the unique characteristics of cancer, so far, these methods have only focused on and existed Unique DNA mutation


    Researcher Dane Vassiliadis said that this study emphasizes the power of SPLINTR technology, which can not only help identify rare tumor subgroups, but also help find new therapeutic targets or biomarkers, and carry out certain clinical monitoring


    However, recent studies have shown that up to 40% of tumors will begin to relapse after initially responding to therapy, but there is no evidence that new gene mutations in cancer cells can explain the resistance to this therapy


    In summary, the results of this article provide relevant data, revealing the researchers' basic insights into the non-genetic transcription process behind the adaptability of malignant clones, which may also provide new clues and clues for later scientists to develop new cancer therapeutic strategies.


    Original source:

    Fennell, KA, Vassiliadis, D.
    , Lam, EYN et al.
    Non-genetic determinants of malignant clonal fitness at single-cell resolution.
    Nature (2021).
    doi: 10.
    1038/s41586-021-04206-7

    Fennell, KA, Vassiliadis, D.
    , Lam, EYN et al Non-genetic determinants of malignant clonal fitness at single-cell resolution Nature (2021) doi:.
    .
    .
    10.
    1038 / s41586-021-04206-7 in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.